Wednesday, September 12, 2018—Although it is often referred to as a neurologic disease that attacks the body and not the mind, cognitive effects in amyotrophic lateral sclerosis (ALS) exist and have been r…
Monday, September 10, 2018—The Food and Drug Administration (FDA) has approved a new formulation of riluzole (Tiglutek; ITF Pharma, Berwyn, PA) for patients with amyotrophic lateral sclerosis (ALS). Thi…
Thursday, September 06, 2018—The Hereditary Neuropathy Foundation (HNF) is holding an externally-led, patient-focused drug development meeting for Charcot-Marie-Tooth disease (CMT) and inherited neuropath…
Wednesday, September 05, 2018—In a small (n = 17 men), double-blind, placebo-controlled study using a counterbalanced within-subjects design, treatment of patients with chronic neuropathic pain with d…
September 2018—A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhD
September 2018—A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics
Rachel Gottlieb-Smith, MD
September 2018—A recently graduated resident and new professor recommends ways to attract medical students to the specialty of neurology.
Stuart B. Black, MD, FAAN
September 2018—Once an uncommon controversial diagnosis, piriformis syndrome is now understood as a sciatic nerve entrapment neuropathy.
